Coreline Soft has won two main awards at the International Forum Design Award 2024 (iF Design Award 2024), an international design competition in Germany.The iF Design Award is the longest-running international design award and is considered one of the world's top three design awards, along with the
The prevalence of heart failure in Korea is steadily rising due to population aging.According to Factsheet 2022, published by the Korean Society of Heart Failure, the prevalence rate in Korea increased significantly from 0.77 percent in 2002 to 2.58 percent in 2020. The number of hospitalizations fo
The second-generation bruton tyrosine kinase (BTK) inhibitor Brukinsa (zanubrutinib), developed by BeiGene, has cleared the threshold of the Pharmaceutical Reimbursement Evaluation Committee (PREC) after a second attempt at expanded coverage.At the same meeting, AstraZeneca's asthma drug Fasenra (be
Professors at the University of Ulsan College of Medicine, including those at Asan Medical Center (AMC) in Seoul, have agreed to submit their resignations in protest against the government's decision to suspend the licenses of resigned interns and residents.The emergency committee of the University
The government allowed "physician assistant" (PA) nurses to practice more at healthcare sites from Friday, issuing supplementary guidelines on the scope of practice for nurses amid ongoing walkouts by trainee doctors and ensuing medical disruptions.The move came as neither trainee doctors nor the go
A research team -- led by Professor Kim Beom-joon of the Neurology Department at Seoul National University Bundang Hospital (SNUBH), together with Professor Kang Dong-Wan from the Neurology Department of the Gyeonggi Provincial Medical Center Icheon Hospital -- has received the "2024 Paul Dudley Whi
In a groundbreaking effort to combat cardiovascular diseases (CVDs) in Asia-Pacific, the Asia-Pacific Cardiovascular Disease Alliance recently released the "A Call for Cohesive Action: Redefining Cardiovascular Care Report," which underscored the region's unique position and ongoing efforts to curb
In response to a mass resignation of trainee physicians that has led to significant medical disruptions, the Korean government said it would spend 200 billion won ($150.1 million) per month into the healthcare system to maintain emergency and patient care.The Ministry of Health and Welfare on Thursd
Samsung Pharm has received approval from the Ministry of Food and Drug Safety (MFDS) to change the investigative new drug (IND) application for its phase 3 clinical trial of GV1001 for Alzheimer's disease.The MFDS accepted Samsung Pharm's application to simplify GV1001's dosing regimen, approving a
Shaperon, a Korean biotech company, said Thursday that it has completed enrollment of the first patient in its U.S. phase 2 clinical trial of NuGel for treating atopic dermatitis.The trial is designed to evaluate NuGel in 210 patients of various ethnicities with mild to moderate atopic dermatitis fo
The 10th Cancer Disease Review Committee (CDRC), under the Health Insurance Review and Assessment Service (HIRA), held its first meeting with newly reconstituted members on Wednesday, during which it discussed nine new and expanded reimbursement proposals.However, most drugs did not pass the review,
In a significant milestone marking the ten-year collaboration between SK bioscience and Sanofi, a global leader in healthcare, the two companies have embarked on an ambitious expansion of the L HOUSE, SK bioscience’s vaccine manufacturing plant in Andong, North Gyeongsang Province.This expansion aim
Concerns are mounting that the government’s push to increase medical school enrollment quota could trigger “medical school craze” among office workers.Some private educational institutions, called hagwon in Korean, and online lecturing firms are “encouraging” office workers to study and apply to med
My Feb. 22 post on X, formerly Twitter, garnered 412,000 views, 723 retweets, and 709 likes as of March 1 at noon. Two days before Daeboreum, a Korean holiday commemorating the first full moon of the New Lunar Year, I shared a brief insight into its significance and attached a photo showcasing tradi
A team of researchers led by Professor Kim Sung-won of the Catholic University of Korea College of Medicine has successfully implanted the "world's first" customized and 3D-bioprinted artificial trachea based on another person's adult stem cells for a patient with an intractable tracheal defect, Cat
University hospitals are grappling with financial difficulties amid prolonged walkouts by trainee doctors, medical sources said.These hospitals have cut back on medical services due to the exodus of interns and residents. As the collective action enters the third week, declining revenue is leading t
Samsung Biologics said Tuesday that it has signed a contract manufacturing agreement worth 381.9 billion won ($352.79 million, based on USD/KRW 1,082.90 on Dec. 21, 2017) with Belgium-based UCB. The contract is an extension of a $41.65 million contract signed with the Belgian company in 2017.UCB is
Curocell, a Kosdaq-listed biotech company, said it received the topline data from its phase 2 clinical trial for its CAR-T (chimeric antigen receptor-T) therapy, Anbal-cel, to treat diffuse large B-cell lymphoma (DLBCL).The study is Korea's first clinical trial of a CAR-T therapy, involving 79 adult
HLB Group has announced the acquisition of domestic rights to Jiangsu Hengrui Pharmaceuticals' immunotherapy, camrelizumab, facilitating the path towards commercializing the combination therapy of camrelizumab and its novel drug candidate riboceranib in Korea.The group's subsidiaries -- HLB Life Sci
Multiple sclerosis (MS) is a rare, intractable disease whose symptoms are caused by damage to the myelin sheath that surrounds the nerve fibers called axons that run throughout the body, including the brain, spinal cord, and optic nerves. When the myelin sheath is damaged, the axons are exposed to t